European Molecular Biology Laboratory

The European Molecular Biology Laboratory (EMBL) is Europe's esteemed lab network for research in molecular biology. EMBL is funded by 20 member states an one associate member. EMBL operates in 5 sites, the main laboratory is in Heidelberg, Germany. Additionally, EMBL manages the European Bioinformatics Institute in Hinxton, Grenoble, Hamburg and Monterotondo near Rome, Italy. Research at EMBL covers the entire spectrum of research in molecular biology. The mission of EMBL is to train scientists at all levels, perform basic molecular biology research and to create new instruments and methods in the broad field of life science and technology development. EMBL has a PhD program and currently has 170 candidates in the program. EMBL publishes updates news about their current research and welcomes the public and media to visit or connect with them about their work.

Address
EMBL Heidelberg Meyerhofstra?e 1 Heidelberg D-69117 Germany
Website
http://emblorg.embl.de/
Wikipedia
http://en.wikipedia.org/wiki/European_Molecular_Biology_Laboratory

Some content from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed

Inflammatory disorders

A promising target to fight inflammatory bowel diseases

Inflammatory bowel diseases (IBDs), such as Crohn's disease or ulcerative colitis, arise when there is a dysregulation of the cell signaling pathways controlling the maintenance of homeostasis in the gut, leading to a chronic ...

Genetics

MAPLE: A phylogenetic tool for pandemic-scale genome data

With the huge abundance of genomic data generated from life science experiments, processing large datasets remains a challenge in the field of bioinformatics. During the COVID-19 pandemic, the limited capabilities of existing ...

Genetics

Large-scale study enables new insights into rare eye disorders

Researchers have analyzed image and genomic data from the UK Biobank to find insights into rare diseases of the human eye. These include retinal dystrophies—a group of inherited disorders affecting the retina—which are ...

Genetics

A human interactome to prioritize drug discovery

Scientists at Open Targets, EMBL's European Bioinformatics Institute (EMBL-EBI), and GSK are revealing the shared basis of diseases using a map of interacting human proteins. By helping to understand how biological processes ...

Medications

Combi-seq: A leap forward for personalized cancer therapy

Each year, around 10 million lives around the world are cut short by cancer. While the last century of research has seen the number of approved anticancer drugs grow by leaps and bounds, the sheer diversity of disease forms ...

page 1 from 8